James Glover has been named CEO of Beckman Coulter, having served as the company’s interim CEO since Aug. 2003.
Glover joined Beckman Coulter in 1983. Since the beginning of 2003, he has served as vice president, controller, and chief accounting officer. While at the company, he has led its capital restructuring and elimination of over $450 million in debt, as well as its risk management program and other efforts related to bond ratings and tax rate.
Glover, a certified public accountant, received his MBA from Pepperdine University and his BS in accounting from California State Polytechnic Institute.
John Lewis has been appointed director of North American sales for Guava Technologies, a provider of microcytometry and cell-counting systems. Lewis has more than 25 years of experience in sales and marketing of life sciences technology. He has held sales and marketing-related positions at several life sciences companies, including Molecular Dynamics, Celera Genomics, and Beckman Coulter.
Lewis received a BS in zoology from the University of Florida.
George Dunbar has been named chief executive officer and board director of Quantum Dot.
Prior to this appointment, Dunbar was the CEO of two drug delivery companies, and he has held board and management positions at several biotechnology companies. Dunbar received an MBA and degree in electrical engineering from Auburn University, and he currently serves on the advisory board of Auburn’s business school.
Quantum Dot’s flagship product, QDot quantum dots, are aimed at a variety of biological applications, including usage as long-term fluorescent tags in cell-based assays.